MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

74.50
+0.14
+0.19%
Opening 10:59 06/16 EDT
OPEN
74.32
PREV CLOSE
74.36
HIGH
74.53
LOW
74.32
VOLUME
1.34K
TURNOVER
--
52 WEEK HIGH
75.00
52 WEEK LOW
58.35
TOTAL ASSET
237.28M
YTD YIELD
-1.48%
1D
5D
1M
3M
1Y
5Y
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Zacks.com · 2d ago
Pharma ETFs in Focus Post Q1 Earnings
Zacks.com · 05/12 08:16
House Democrats reintroduce bill to lower drug prices
Rep. Frank Pallone, Jr. (D-N.J.) reintroduced H.R. 3, legislation that would allow the federal government to negotiate prescription drug prices.The bill would cap seniors' out-of-pocket costs on prescription drugs to
Seekingalpha · 04/22 19:47
Big Pharma is pushing back the pandemic, but its stocks are cheap - Barron's
Drugmakers are set to save the world from COVID-19 but their shares have lagged the broader market in the past year, making the group look like one of the best
Seekingalpha · 03/14 05:40
Yes, Bond ETFs Can Go Haywire. But That’s a Good Thing, Says BIS
Critics of the passive-investing boom in bonds warn about the risks stemming from the mismatch between highly tradable ETFs and the illiquid securities they hold.
Bloomberg · 03/01 12:00
As a Treasuries Rout Went Global, China’s Bonds Shone on Alone
As investors fled almost every fixed-income asset from the safest government bonds to the highest-yielding securities last week, one market stood out as a haven.
Bloomberg · 03/01 11:00
Cathie Wood’s Power in Some Stocks Is Even Bigger Than It Seems
A rough week for Cathie Wood is reminding Wall Street that Ark Investment Management has a lot of cash in not that many companies. In fact, the firm’s dominance in some stocks may be even greater than it seems.
Bloomberg · 02/27 21:00
Pharma ETFs in Focus Post Q4 Earnings
Zacks.com · 02/05 17:40
More
No Data
Learn about the latest financial forecast of PPH. Analyze the recent business situations of VanEck Vectors Pharmaceutical ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1712%
--
1-Week
-2.4151%
--
1-Month
-2.9895%
--
3-Month
-1.3098%
--
6-Month
4.8724%
--
YTD
-1.4781%
--
1-Year
12.4328%
--
3-Year
5.9871%
--
5-Year
0.5642%
--
Since Inception
8.8357%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin